Hydroxyzine Should Not Be Used as a Sleep Aid
Hydroxyzine is not recommended for the treatment of insomnia in adults. The American Academy of Sleep Medicine 2017 clinical practice guideline does not include hydroxyzine among recommended pharmacologic treatments for chronic insomnia 1. This represents the most authoritative guidance on insomnia pharmacotherapy and notably excludes hydroxyzine from consideration.
Why Hydroxyzine Is Not Recommended for Sleep
The AASM guideline specifically recommends against using antihistamines like diphenhydramine for insomnia treatment 1. While hydroxyzine is not explicitly mentioned, it belongs to the same class of first-generation antihistamines with similar mechanisms and side effect profiles. The guideline's negative recommendation for diphenhydramine at 50 mg doses reflects concerns about this entire drug class for sleep disorders.
FDA-Approved Dosing (Not for Sleep)
The FDA label for hydroxyzine does not include insomnia as an approved indication 2. The approved uses and dosing are:
- Anxiety/tension: 50-100 mg four times daily in adults
- Pruritus: 25 mg three to four times daily in adults
- Preoperative sedation: 50-100 mg as a single dose
Maximum daily dose from FDA labeling: 400 mg/day (100 mg four times daily for anxiety), though this is not for sleep purposes 2.
Evidence on Hydroxyzine for Sleep
A 2023 systematic review found only mixed efficacy for hydroxyzine in treating insomnia, with studies using 25-100 mg at bedtime 3. The review identified significant limitations:
- Only 5 small studies (207 total patients)
- Inconsistent results across sleep measures
- Most studies failed to report safety outcomes adequately
- No long-term data available
One study showed 65% of patients had improved sleep efficiency with hydroxyzine 25 mg at bedtime versus 25% with placebo 4, but this was in cirrhotic patients with hepatic encephalopathy—a specialized population where one patient developed acute encephalopathy requiring drug cessation 4.
Serious Safety Concerns
QT Prolongation and Cardiac Arrhythmias
Hydroxyzine carries FDA warnings for QT prolongation and Torsade de Pointes 2. The drug should be used with extreme caution or avoided in patients with:
- Pre-existing heart disease
- Electrolyte imbalances
- Congenital long QT syndrome
- Recent myocardial infarction
- Uncompensated heart failure
- Concurrent use of other QT-prolonging medications
This is particularly problematic because many patients seeking sleep aids are older adults with cardiac comorbidities.
Additional Risks
- CNS depression: Potentiates effects of other sedatives, narcotics, and alcohol 2
- Anticholinergic effects: Dry mouth, confusion, and oversedation, especially in elderly 2
- AGEP (Acute Generalized Exanthematous Pustulosis): Rare but serious skin reaction 2
- Elderly vulnerability: Higher risk of confusion, falls, and oversedation; should start at low doses 2
What to Use Instead
The AASM guideline provides clear alternatives with weak recommendations (meaning clinicians should use clinical judgment) 1:
For Sleep Onset Insomnia:
- Zolpidem 10 mg
- Zaleplon 10 mg
- Triazolam 0.25 mg
- Ramelteon 8 mg
For Sleep Maintenance Insomnia:
- Suvorexant 10-20 mg
- Doxepin 3-6 mg
- Eszopiclone 2-3 mg
For Both Sleep Onset and Maintenance:
- Eszopiclone 2-3 mg
- Zolpidem 10 mg
- Temazepam 15 mg
The American College of Physicians 2016 guideline emphasizes that cognitive behavioral therapy for insomnia (CBT-I) should be the first-line treatment before considering any pharmacotherapy 5.
Critical Caveats
- Off-label use: Any use of hydroxyzine for sleep is off-label and lacks robust evidence
- Short-term only: If hydroxyzine is used despite recommendations against it, limit to short-term use (days to weeks, not months)
- Dose range in literature: Studies used 25-100 mg at bedtime, but this does not constitute a recommendation 3, 4
- Elderly patients: Start at 25 mg or lower due to increased sensitivity and risk of adverse effects 2
- Drug interactions: Screen carefully for QT-prolonging medications and CNS depressants 2
Clinical Bottom Line
Do not prescribe hydroxyzine for insomnia. Use evidence-based alternatives recommended by the AASM guideline, or preferably, refer for CBT-I. If a patient is already taking hydroxyzine for sleep, consider transitioning to an appropriate alternative while addressing the underlying sleep disorder with non-pharmacologic approaches.